{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:51:40Z","timestamp":1791287500414,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd005171","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2008,1,23]],"date-time":"2008-01-23T00:00:00Z","timestamp":1201046400000}}],"reference-count":34,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005171.pub2","type":"journal-article","created":{"date-parts":[[2008,2,5]],"date-time":"2008-02-05T21:12:31Z","timestamp":1202245951000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Oxcarbazepine in the maintenance treatment of bipolar disorder"],"prefix":"10.1002","volume":"2010","author":[{"given":"Akshya","family":"Vasudev","sequence":"first","affiliation":[{"name":"Centre for Health of the Elderly; Castleside Offices; Newcastle General Hospital Newcastle Upon Tyne UK NE4 6BE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Macritchie","sequence":"additional","affiliation":[{"name":"University of British Columbia; Department of Psychiatry; Suite 430 Strangway Building 5950 University Boulevard Vancouver  Canada V6T 1Z3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Watson","sequence":"additional","affiliation":[{"name":"Royal Victoria Infirmary; Department of Psychiatry, Leazes Wing; Queen Victoria Rd Newcastle-upon-Tyne Tyne and Wear UK NE1 4LP"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Geddes","sequence":"additional","affiliation":[{"name":"University of Oxford; Department of Psychiatry; Warneford Hospital Oxford UK OX3 7JK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan H","family":"Young","sequence":"additional","affiliation":[{"name":"University of British Columbia; Department of Psychiatry; Suite 430 Strangway Building 5950 University Boulevard Vancouver Canada V6T 1Z3"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,1,23]]},"reference":[{"key":"10.1002\/14651858.CD005171.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1055\/s-2007-1017235","article-title":"Long term randomized clinical trial on oxcarbazepine vs lithium in bipolar and schizoaffective disorders: Preliminary results","volume":"19","author":"Cabrera","year":"1986","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD005171.pub2-BIB0002|cit2","first-page":"89","article-title":"Case studies on prophylactic long term effects of oxcarbazepine in recurrent affective disorder","volume":"5 Suppl 1","author":"Wildgrube","year":"1990","journal-title":"International Clinical Psychopharmacology"},{"issue":"10","key":"10.1002\/14651858.CD005171.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2165\/00044011-200323100-00006","article-title":"Oxcarbazepine versus divalproex sodium for the continuing treatment of mania","volume":"23","author":"Reinstein","year":"2003","journal-title":"Clinical Drug Investigation"},{"issue":"7","key":"10.1002\/14651858.CD005171.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1176\/ajp.2006.163.7.1179","article-title":"A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents","volume":"163","author":"Wagner","year":"2006","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD005171.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S0165-0327(00)00203-2","article-title":"Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders","volume":"59 Suppl 1","author":"Akiskal","year":"2000","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD005171.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005171.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0006-3223(00)00909-4","article-title":"Historical perspectives and natural history of bipolar disorder","volume":"48","author":"Angst","year":"2000","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD005171.pub2-BIB0008|cit8","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/14651858.CD005171.pub2-BIB0009|cit9","unstructured":"American Psychiatic Associaton Practice Guideline for the Treatment of Patients with Bipolar Disorder 2nd Edition On-line addition: http:\/\/www.psych.org\/psych_pract\/treatg\/pg\/Bipolar2ePG_05-15-06.pdf 2002"},{"key":"10.1002\/14651858.CD005171.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0165-0327(02)00407-X","article-title":"Oxcarbazepine as add-on treatment in patients with bipolar, manic, mixed or depressive episode","volume":"79","author":"Benedetti","year":"2004","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD005171.pub2-BIB0011|cit11","volume-title":"British National Formulary","author":"Various","year":"2007"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD005171.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"48S","DOI":"10.1097\/00004714-199604001-00006","article-title":"Role of newer medications for bipolar disorder","volume":"16","author":"Bowden","year":"1996","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD005171.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/001316446002000104","article-title":"A coefficient of agreement for nominal scales","volume":"20","author":"Cohen","year":"1960","journal-title":"Educational and Psychological Measurement"},{"key":"10.1002\/14651858.CD005171.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1987","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD005171.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1055\/s-2001-18036","article-title":"Oxcarbazepine in affective and schizoaffective disorders","volume":"34","author":"Dietrich","year":"2001","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD005171.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1212\/01.wnl.0000188819.45330.90","article-title":"Hyponatremia from oxcarbazepine and carbamazepine","volume":"65","author":"Dong","year":"2005","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD005171.pub2-BIB0017|cit17","volume-title":"Statistical Methods for Rates and Proportions","author":"Fleiss","year":"1981"},{"key":"10.1002\/14651858.CD005171.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1192\/bjp.164.2.149","article-title":"Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder","volume":"164","author":"Goodwin","year":"1994","journal-title":"British Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD005171.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/0269881103017002003","article-title":"Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology","volume":"17","author":"Goodwin","year":"2003","journal-title":"British Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD005171.pub2-BIB0020|cit20","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions 4.2.4. In The Cochrane Library","author":"Higgins","year":"2005"},{"key":"10.1002\/14651858.CD005171.pub2-BIB0021|cit21","first-page":"502","article-title":"A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder","volume":"7","author":"Hirschfeld","year":"2000","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD005171.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1528-1157.1994.tb01792.x","article-title":"Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxcarbazepine.","volume":"35","author":"Isojarvi","year":"1994","journal-title":"Epilepsia"},{"issue":"1","key":"10.1002\/14651858.CD005171.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD005171.pub2-BIB0024|cit24","unstructured":"NICE guidelines: Bipolar disorder. The management of bipolar disorder in adults, children and adolescents, in primary and secondary care Guidance type: Clinical guideline http:\/\/www.nice.org.uk\/CG38 2006"},{"key":"10.1002\/14651858.CD005171.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00431111","article-title":"A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness","volume":"73","author":"Okuma","year":"1981","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD005171.pub2-BIB0026|cit26","article-title":"Preparing and maintaining systematic reviews.","volume-title":"Cochrane Collaboration Handbook","volume":"section VI, upd","author":"Oxman","year":"1995"},{"key":"10.1002\/14651858.CD005171.pub2-BIB0027|cit27","volume-title":"Physicians Desk Reference","author":"Various","year":"2001"},{"issue":"6","key":"10.1002\/14651858.CD005171.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1586\/14737175.7.6.617","article-title":"Oxcarbazepine in the treatment of bipolar and schizoaffective disorders","volume":"7","author":"Popova","year":"2007","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"5","key":"10.1002\/14651858.CD005171.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD005171.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1399-5618.2007.00468.x","article-title":"Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials","volume":"9","author":"Smith","year":"2007","journal-title":"Bipolar Disorder"},{"key":"10.1002\/14651858.CD005171.pub2-BIB0031|cit31","volume-title":"The World Health Organisation. The ICD-10 Classification of mental and behavioural disorders. Clinical descriptions and diagnostic guidelines","author":"World Health Organisation","year":"1992"},{"key":"10.1002\/14651858.CD005171.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1399-5618.2005.00219.x","article-title":"Canadian Network for Mood and Anxiety Treatments. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies","volume":"7 Suppl 3","author":"Yatham","year":"2005","journal-title":"Bipolar Disorders"},{"issue":"6","key":"10.1002\/14651858.CD005171.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1399-5618.2006.00432.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007","volume":"8","author":"Yatham","year":"2006","journal-title":"Bipolar Disorders"},{"issue":"CD004694","key":"10.1002\/14651858.CD005171.pub2-BIB0034|cit34","article-title":"Tiagabine in the treatment of acute affective episodes in bipolar disorder: efficacy and acceptability.","author":"Young","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD005171.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:01:41Z","timestamp":1791284501000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005171.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Common Mental Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2008,1,23]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005171.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,23]]}}}